share_log

CVS Health | 10-Q: Quarterly report

CVS Health | 10-Q: Quarterly report

西維斯健康 | 10-Q:季度報表
美股sec公告 ·  05/01 18:44
牛牛AI助理已提取核心訊息
CVS Health reported a decrease in operating income for the first quarter of 2024, with operating income falling to $2.271 billion from $3.446 billion in the same period last year. Adjusted operating income also declined to $2.957 billion from $4.370 billion year-over-year. The company's total revenues, however, saw a slight increase of 3.7%, reaching $88.437 billion, driven by growth in the Health Care Benefits and Pharmacy & Consumer Wellness segments, despite a decline in the Health Services segment. Net income attributable to CVS Health saw a significant drop of 47.9%, from $2.136 billion to $1.113 billion. The Health Care Benefits segment experienced a 24.6% increase in total revenues, while the Health Services segment's revenues decreased by 9.7%. The Pharmacy & Consumer Wellness segment's revenues increased by 2.9%. CVS Health's future plans include growth in its new Cordavis, Oak Street Health, and Signify Health businesses, and the company expects to continue sharing a larger portion of rebates, fees, and discounts with clients. The company also anticipates ongoing enterprise-wide cost savings initiatives and investments in efficiencies to reduce operating costs sustainably.
CVS Health reported a decrease in operating income for the first quarter of 2024, with operating income falling to $2.271 billion from $3.446 billion in the same period last year. Adjusted operating income also declined to $2.957 billion from $4.370 billion year-over-year. The company's total revenues, however, saw a slight increase of 3.7%, reaching $88.437 billion, driven by growth in the Health Care Benefits and Pharmacy & Consumer Wellness segments, despite a decline in the Health Services segment. Net income attributable to CVS Health saw a significant drop of 47.9%, from $2.136 billion to $1.113 billion. The Health Care Benefits segment experienced a 24.6% increase in total revenues, while the Health Services segment's revenues decreased by 9.7%. The Pharmacy & Consumer Wellness segment's revenues increased by 2.9%. CVS Health's future plans include growth in its new Cordavis, Oak Street Health, and Signify Health businesses, and the company expects to continue sharing a larger portion of rebates, fees, and discounts with clients. The company also anticipates ongoing enterprise-wide cost savings initiatives and investments in efficiencies to reduce operating costs sustainably.
CVS Health報告稱,2024年第一季度的營業收入有所下降,營業收入從去年同期的34.46億美元降至22.71億美元。調整後的營業收入也從同比的43.70億美元降至29.57億美元。但是,儘管健康服務板塊下滑,但該公司的總收入仍略有增長3.7%,達到884.37億美元,這得益於醫療保健福利以及藥房和消費者健康板塊的增長。歸屬於CVS Health的淨收入大幅下降了47.9%,從21.36億美元降至11.13億美元。醫療保健福利板塊的總收入增長了24.6%,而健康服務板塊的收入下降了9.7%。藥房和消費者健康板塊的收入增長了2.9%。CVS Health的未來計劃包括增長其新的Cordavis、Oak Street Health和Signify Health業務,該公司預計將繼續與客戶分享更大的回扣、費用和折扣。該公司還預計,企業範圍內的成本節約計劃和效率投資將持續進行,以可持續地降低運營成本。
CVS Health報告稱,2024年第一季度的營業收入有所下降,營業收入從去年同期的34.46億美元降至22.71億美元。調整後的營業收入也從同比的43.70億美元降至29.57億美元。但是,儘管健康服務板塊下滑,但該公司的總收入仍略有增長3.7%,達到884.37億美元,這得益於醫療保健福利以及藥房和消費者健康板塊的增長。歸屬於CVS Health的淨收入大幅下降了47.9%,從21.36億美元降至11.13億美元。醫療保健福利板塊的總收入增長了24.6%,而健康服務板塊的收入下降了9.7%。藥房和消費者健康板塊的收入增長了2.9%。CVS Health的未來計劃包括增長其新的Cordavis、Oak Street Health和Signify Health業務,該公司預計將繼續與客戶分享更大的回扣、費用和折扣。該公司還預計,企業範圍內的成本節約計劃和效率投資將持續進行,以可持續地降低運營成本。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。